These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 10419853

  • 1. Interfering with chemokine networks--the hope for new therapeutics.
    Schwarz MK, Wells TN.
    Curr Opin Chem Biol; 1999 Aug; 3(4):407-17. PubMed ID: 10419853
    [Abstract] [Full Text] [Related]

  • 2. Chemokine blockers--therapeutics in the making?
    Wells TN, Power CA, Shaw JP, Proudfoot AE.
    Trends Pharmacol Sci; 2006 Jan; 27(1):41-7. PubMed ID: 16310864
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Anti-chemokine small molecule drugs: a promising future?
    Proudfoot AE, Power CA, Schwarz MK.
    Expert Opin Investig Drugs; 2010 Mar; 19(3):345-55. PubMed ID: 20113217
    [Abstract] [Full Text] [Related]

  • 6. Chemokine receptors: attractive targets for drug discovery.
    Godessart N.
    Ann N Y Acad Sci; 2005 Jun; 1051():647-57. PubMed ID: 16127005
    [Abstract] [Full Text] [Related]

  • 7. Virus-encoded chemokine receptors--putative novel antiviral drug targets.
    Rosenkilde MM.
    Neuropharmacology; 2005 Jan; 48(1):1-13. PubMed ID: 15617722
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A burgeoning family of biological mediators: chemokines and chemokine receptors.
    Le Y, Gong W, Shen W, Li B, Dunlop NM, Wang JM.
    Arch Immunol Ther Exp (Warsz); 2000 Jan; 48(3):143-50. PubMed ID: 10912618
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Chemokine-receptor interactions: GPCRs, glycosaminoglycans and viral chemokine binding proteins.
    Lau EK, Allen S, Hsu AR, Handel TM.
    Adv Protein Chem; 2004 Jan; 68():351-91. PubMed ID: 15500866
    [Abstract] [Full Text] [Related]

  • 13. Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice.
    Wareing MD, Lyon AB, Lu B, Gerard C, Sarawar SR.
    J Leukoc Biol; 2004 Oct; 76(4):886-95. PubMed ID: 15240757
    [Abstract] [Full Text] [Related]

  • 14. The chemokine network: a target in cancer biology?
    Slettenaar VI, Wilson JL.
    Adv Drug Deliv Rev; 2006 Oct 01; 58(8):962-74. PubMed ID: 16996642
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Post-translational control of chemokines: a role for decoy receptors?
    Comerford I, Nibbs RJ.
    Immunol Lett; 2005 Jan 31; 96(2):163-74. PubMed ID: 15585320
    [Abstract] [Full Text] [Related]

  • 17. Targeting the chemokine system for multiple sclerosis treatment.
    Glabinsk AR, Ransohoff RM.
    Curr Opin Investig Drugs; 2001 Dec 31; 2(12):1712-9. PubMed ID: 11892933
    [Abstract] [Full Text] [Related]

  • 18. [Blockade of chemokines in chronic inflammatory diseases].
    Haringman JJ, Tak PP.
    Ned Tijdschr Geneeskd; 2004 Sep 04; 148(36):1760-4. PubMed ID: 15495938
    [Abstract] [Full Text] [Related]

  • 19. Antiviral potential of chemokines.
    Mahalingam S, Clark K, Matthaei KI, Foster PS.
    Bioessays; 2001 May 04; 23(5):428-35. PubMed ID: 11340624
    [Abstract] [Full Text] [Related]

  • 20. Chemokines and their receptors in islet allograft rejection and as targets for tolerance induction.
    Merani S, Truong WW, Hancock W, Anderson CC, Shapiro AM.
    Cell Transplant; 2006 May 04; 15(4):295-309. PubMed ID: 16898223
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.